Carotid artery plaque examinations performed with serial ultrasound scans could help identify patients at high risk for a heart attack or other potentially lethal cardiovascular conditions.
Dr. Markus Reiter, at the Medical University of Vienna, evaluated 1268 asymptomatic patients at high risk of cardiovascular disease using computer-assisted gray-scale median (GSM) ultrasound carotid measurements. Plaque volume identified carotid disease in 574 patients who had a second ultrasound exam six to nine months later to measure plaque changes. Nearly half of those patients had lower GSM levels, and 37% experienced a major adverse cardiovascular event, such as a heart attack, a stroke, or cardiac surgery, within three years of the second ultrasound. Vulnerable carotid plaque indicated not only increased risk of stroke but also disease progression elsewhere in the cardiovascular system.
Study results appeared in the September issue of Radiology.
Can Intestinal Ultrasound Provide an Alternative for Evaluating Creeping Fat with Crohn’s Disease?
September 25th 2024Intestinal ultrasound demonstrated an 88.2 percent agreement with computed tomography enterography in characterizing creeping fat in patients with Crohn’s disease, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.